Transaction · 0001993147-26-000004
BIO BIO.BBIO-RAD LABORATORIES, INC.
Evran Sedat
EVRAN SEDAT, EVP, GSC, reported a transaction classified as exercise at BIO-RAD LABORATORIES, INC. involving 1044.000000 shares for an estimated $0.00. Reported holdings after the transaction were 4647.120000 shares. A 10b5-1 reference was not detected in the stored filing text.
exerciseSEC transaction code MEVP, GSC
- Trade date
- Oct 20, 2026
- Filing date
- Oct 22, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BIO BIO.B price since this filing
Daily closing prices, with the filing date and available return windowsBIO BIO.B · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001993147-26-000004 Bio-Rad A Common Stock
- Transaction date
- Oct 20, 2026 Filed Oct 22, 2026, 09:55 PM · 2d delay
- Shares
- 1,044 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 4,647.12 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
Positive filing signal
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 2
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
EVP, Global Supply Chain
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3
On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Related transactions
Same SEC filing0 other transactions
Recent company activity
BIO BIO.B0 recent txs